Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F F Rutten

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Health Policy (Amsterdam, Netherlands)|March 11, 1987
Market strategies for publicly financed health care systemsF F Rutten
Nederlands Tijdschrift Voor Geneeskunde|August 5, 2000
[Roaming through methodology. XIX. Cost-effectiveness ratios]F F Rutten
Nederlands Tijdschrift Voor Geneeskunde|November 19, 1994
[Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine]W Bergman, F F Rutten
Social Science & Medicine (1982)|August 1, 1997
Economic evaluation in support of national health policy: the case of The NetherlandsE Elsinga, F F Rutten
Health Economics|November 1, 1994
The impact of indirect costs on outcomes of health care programsM A Koopmanschap, F F Rutten
Pharmacoeconomics|October 4, 1996
A practical guide for calculating indirect costs of diseaseM A Koopmanschap, F F Rutten
Pharmacoeconomics|November 4, 1993
Indirect costs in economic studies: confronting the confusionM A Koopmanschap, F F Rutten
Nederlands Tijdschrift Voor Geneeskunde|December 1, 1999
[Conditions for introduction and financing of new technologies]F F Rutten, E W Grijseels
Health Policy (Amsterdam, Netherlands)|December 11, 1985
Health care financing in the Netherlands: recent changes and future optionsF F Rutten, R J Freens
Social Science & Medicine (1982)|August 1, 1992
High cost technology in health care: a benefit or a burden?F F Rutten, G J Bonsel
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Health Policy (Amsterdam, Netherlands)|March 11, 1987
Market strategies for publicly financed health care systemsF F Rutten
Nederlands Tijdschrift Voor Geneeskunde|August 5, 2000
[Roaming through methodology. XIX. Cost-effectiveness ratios]F F Rutten
Nederlands Tijdschrift Voor Geneeskunde|November 19, 1994
[Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine]W Bergman, F F Rutten
Social Science & Medicine (1982)|August 1, 1997
Economic evaluation in support of national health policy: the case of The NetherlandsE Elsinga, F F Rutten
Health Economics|November 1, 1994
The impact of indirect costs on outcomes of health care programsM A Koopmanschap, F F Rutten
Pharmacoeconomics|October 4, 1996
A practical guide for calculating indirect costs of diseaseM A Koopmanschap, F F Rutten
Pharmacoeconomics|November 4, 1993
Indirect costs in economic studies: confronting the confusionM A Koopmanschap, F F Rutten
Nederlands Tijdschrift Voor Geneeskunde|December 1, 1999
[Conditions for introduction and financing of new technologies]F F Rutten, E W Grijseels
Health Policy (Amsterdam, Netherlands)|December 11, 1985
Health care financing in the Netherlands: recent changes and future optionsF F Rutten, R J Freens
Social Science & Medicine (1982)|August 1, 1992
High cost technology in health care: a benefit or a burden?F F Rutten, G J Bonsel
Pageof 9